Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Diagnosing PCOS in teenagers should focus on signs of excess male hormones and not rely solely on ovarian ultrasound or irregular periods, and should be reassessed in adulthood.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Bariatric surgery improves ovulation rates in women with PCOS and obesity better than medical therapy.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

Menstrual abnormalities in PCOS women may not greatly affect their metabolic and hormonal profile.

People with certain skin conditions, especially androgenic alopecia, are more likely to have metabolic syndrome.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Long-term finasteride treatment reduces depression and brain issues in obese male rats.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

Men with early hair loss may have higher insulin resistance and should be checked for related health issues.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Quercetin may help with PCOS symptoms, but more research is needed.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

A male with aromatase deficiency improved bone health with estradiol treatment.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.